{"prompt": "['Page 68 of 74', 'Protocol 036 (Nishijima, Kuppermann)', '[34] S. Beno, A. D. Ackery, J. Callum, and S. Rizoli. Tranexamic acid in pediatric trauma:', 'Why not? Crit Care, 18(4):313, 2014.', '[35] L. De Pietri, M. Bianchini, R. Montalti, N. De Maria, T. Di Maira, B. Begliomini, G. E.', 'Gerunda, F. di Benedetto, G. Garcia-Tsao, and E. Villa. Thrombelastography-guided', 'blood product use before invasive procedures in cirrhosis with severe coagulopathy. a', 'randomized controlled trial. Hepatology, 2015.', '[36] W. Sun, K. Jeleniowski, X. Zhao, P. Shen, D. Li, and J. A. Hammond. Throm-', 'boelastography (teg)-based algorithm reduces blood product utilization in patients', 'undergoing vad implant. J Card Surg, 29(2):238-43, 2014.', '[37] J. Yin, Z. Zhao, Y. Li, J. Wang, D. Yao, S. Zhang, W. Yu, N. Li, and J. Li. Goal-', 'directed transfusion protocol via thrombelastography in patients with abdominal', 'trauma: A retrospective study. World J Emerg Surg, 9:28, 2014.', '[38] B. A. Cotton, J. A. Harvin, V. Kostousouv, K. M. Minei, Z. A. Radwan, H. Schochl,', 'C. E. Wade, J. B. Holcomb, and N. Matijevic. Hyperfibrinolysis at admission is', 'an uncommon but highly lethal event associated with shock and prehospital fluid', 'administration. J Trauma Acute Care Surg, 73(2):365-70; discussion 370, 2012.', '[39] M. P. Chapman, E. E. Moore, C. R. Ramos, A. Ghasabyan, J. N. Harr, T. L. Chin,', 'J. R. Stringham, A. Sauaia, C. C. Silliman, and A. Banerjee. Fibrinolysis greater', 'than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute', 'Care Surg, 75(6):961-7; discussion 967, 2013.', '[40] C. Ives, K. Inaba, B. C. Branco, O. Okoye, H. Schochl, P. Talving, L. Lam, I. Shulman,', 'J. Nelson, and D. Demetriades. Hyperfibrinolysis elicited via thromboelastography', 'predicts mortality in trauma. J Am Coll Surg, 215(4):496-502, 2012.', '[41]', 'M. E. Kutcher, M. W. Cripps, R. C. McCreery, I. M. Crane, M. D. Greenberg, L. M.', 'Cachola, B. J. Redick, M. F. Nelson, and M. J. Cohen. Criteria for empiric treatment', 'of hyperfibrinolysis after trauma. J Trauma Acute Care Surg, 73(1):87-93, 2012.', '[42] B. J. Hunt, I. Raza, and K. Brohi. The incidence and magnitude of fibrinolytic', 'activation in trauma patients: A reply to a rebuttal. J Thromb Haemost, 11(7):1437-8,', '2013.', '[43] I. Raza, R. Davenport, C. Rourke, S. Platton, J. Manson, C. Spoors, S. Khan, H. D.', \"De'Ath, S. Allard, D. P. Hart, K. J. Pasi, B. J. Hunt, S. Stanworth, P. K. MacCallum,\", 'and K. Brohi. The incidence and magnitude of fibrinolytic activation in trauma', 'patients. J Thromb Haemost, 1(2):307-14, 2013.', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Protocol 036 (Nishijima, Kuppermann)', 'Page 69 of 74', '[44] G. N. Jackson, K. J. Ashpole, and S. M. Yentis. The TEG VS the ROTEM throm-', 'poelastography/thromboelastometry systems. Anaesthesia, 64(2):212-5, 2009.', '[45] C. R. Ramos, E. E. Moore, M. L. Manco-Johnson, C. C. Silliman, M. C. Chapman,', 'and A. Banerjee. The incidence and magnitude of fibrinolytic activation in trauma', 'patients: A rebuttal. J Thromb Haemost, 11 ):1435-7, 2013.', '[46] J. A. Harvin, C. A. Peirce, M. M. Mims, J. A. Hudson, J. M. Podbielski, C. E. Wade,', 'J. B. Holcomb, and B. A. Cotton. The impact of tranexamic acid on mortality in', 'injured patients with hyperfibrinolysis. J Trauma Acute Care Surg, 78(5):905-9;', 'discussion 909-11, 2015.', '[47] A. Koster, D. Faraoni, and J. H. Levy. Antifibrinolytic therapy for cardiac surgery:', 'An update. Anesthesiology, 123(1):214-21, 2015.', '[48] D. K. Nishijima, M. C. Monuteaux, D. Faraoni, S. M. Goobie, L. Lee, J. Galante,', \"J. F. Holmes, and N. Kuppermann. Tranexamic acid use in United States children's\", 'hospitals. J Emerg Med, 50(6):868-874 e1, 2016.', '[49] World Health Association.', 'Tranexemic acid:', 'Selection', 'as', 'who', 'essential', 'medication.', 'Accessed', 'November', '26,', '2015', 'from', ' http://www.who.int/selectionmedicines/committees/expert/17/application/tranexamic/en/.', '[50] B. Bojko, D. Vuckovic, F. Mirnaghi, E. Cudjoe, M. Wasowicz, A. Jerath, and', 'J. Pawliszyn. Therapeutic monitoring of tranexamic acid concentration: High-', 'throughput analysis with solid-phase microextraction. Ther Drug Monit, 34(1):31-7,', '2012.', '[51] S. Grassin-Delyle, B. Tremey, E. Abe, M. Fischler, J. C. Alvarez, P. Devillier, and', 'S. Urien. Population pharmacokinetics of tranexamic acid in adults undergoing', 'cardiac surgery with cardiopulmonary bypass. Br J Anaesth, 111 (6):916-24, 2013.', '52 S. Sigaut, B. Tremey, A. Ouattara, R. Couturier, C. Taberlet, S. Grassin-Delyle,', 'J. F. Dreyfus, S. Schlumberger, and M. Fischler. Comparison of two doses of', 'tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.', 'Anesthesiology, 120(3):590-600, 2014.', '[53] C. Valdez, B. Sarani, H. Young, R. Amdur, J. Dunne, and L. S. Chawla. Timing of', 'death after traumatic injury-a contemporary assessment of the temporal distribution', 'of death. J Surg Res, 200(2):604-9, 2016.', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']\n\n###\n\n", "completion": "END"}